Trophoblastic Tumor Placental SiteSymptoms, Doctors, Treatments, Advances & More
Trophoblastic Tumor Placental Site Overview
Learn About Trophoblastic Tumor Placental Site
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Tower Health Medical Group Gynecologic Oncology - West Reading
Bernice Robinson is an Oncologist and an Obstetrics and Gynecologist practicing medicine in West Reading, Pennsylvania. Dr. Robinson is rated as an Experienced provider by MediFind in the treatment of Trophoblastic Tumor Placental Site. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, Cervical Cancer, and Bladder Reconstruction. Dr. Robinson is board certified in American Board Of Obstetrics And Gynecology.
Advocate Medical Group Primary Care
Shuang Yao is a primary care provider, practicing in Family Medicine in Chicago, Illinois. Dr. Yao is rated as an Experienced provider by MediFind in the treatment of Trophoblastic Tumor Placental Site. Her clinical expertise encompasses Type 2 Diabetes (T2D), Trophoblastic Tumor Placental Site, Hypertension, Heart Tumor, and Hepato-Pancreato-Biliary Surgery. Dr. Yao is board certified in American Board Of Family Medicine.
Hextan Ngan practices practicing medicine in Hong Kong, Hong Kong Special Administrative Region. Ms. Ngan is rated as a Distinguished expert by MediFind in the treatment of Trophoblastic Tumor Placental Site. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Trophoblastic Tumor Placental Site, Hydatidiform Mole, Gestational Trophoblastic Disease, Hysterectomy, and Endoscopy.
Summary: The purpose of this study is to establish a prospective, single-center platform research based on clinical subtypes to explore precision neoadjuvant therapy in patients with operable breast cancer who met the indications for neoadjuvant chemotherapy and by the update of basic translational research in the center, especially the refinement of typing, the discovery of new targets and the development...


